突破界限:探索抗凝血和血栓形成管理的最新进展:全面审查
Zaheer Qureshi1, Faryal Altaf2, Abdur Jamil3
1The Frank H. Netter M.D. School of Medicine at Quinnipiac University, Bridgeport, Connecticut, USA.
Annals of medicine and surgery (2012)
|November 11, 2024
概括
新的抗凝剂在减少出血和血栓塞栓事件方面表现有前途. 持续的研究对于个性化抗凝治疗和改善患者治疗这些疾病的结果至关重要.
科学领域:
- 心脏病学 心脏病学
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 血栓塞栓性疾病是全球疾病和死亡的主要原因之一.
- 有效的抗凝血和血栓形成管理对于预防严重并发症至关重要.
- 抗凝固药疗法的进步对于改善患者的治疗结果至关重要.
研究的目的:
- 审查最近抗凝疗法和药物输送系统的进展.
- 评估新型抗凝血剂的有效性和安全性.
- 为了确定当前的挑战和未来的方向在抗凝血.
主要方法:
- 对最近的临床试验,元分析和指南出版物的系统审查.
- 分析了包括PACIFIC-AF,RIVER,ENAVLE,ENVISAGE-TAVI AF和ARCADIA在内的关键研究.
- 对新型抗凝剂的安全性和有效性数据的评估.
主要成果:
- 阿桑德西安显示出34%的降低出血与阿皮克萨班 (PACIFIC-AF) 相比.
- 里瓦洛克萨班减少了20%的出血,而华法林则降低了20% (RIVER).
- 埃多克萨班降低了血栓塞栓事件3.7%与华法林 (ENAVLE) 相比,在预防事件方面没有劣势,但略有增加出血 (ENVISAGE-TAVI AF). 阿皮克萨班和阿司匹林显示出类似的中风率 (ARCADIA).
结论:
- 新型抗凝血剂和药物输送系统为血栓栓塞性疾病提供了潜在的好处.
- 患者特异性反应和监测仍然是需要进一步调查的领域.
- 需要持续创新,以优化抗凝实践和个性化治疗.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.8K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.8K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.6K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.6K
01:24Disorders of Hemostasis
2.7K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.7K
01:29Venous Thrombosis III: Interprofessional Care
482
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482
01:30Venous Thrombosis IV: Nursing Management
418
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
418